Healthcare Realty Trust (HR) Stock Forecast & Price Target

$18.02

-0.17 (-0.93%)

(As of 09/18/2024 ET)

Healthcare Realty Trust - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold
Based on 8 Analyst Ratings

Based on 8 Wall Street analysts who have issued ratings for Healthcare Realty Trust in the last 12 months, the stock has a consensus rating of "Hold." Out of the 8 analysts, 1 has given a sell rating, 5 have given a hold rating, and 2 have given a buy rating for HR.

Consensus Price Target

$17.00
-5.69% Downside

High Forecast	$18.00
Average Forecast	$17.00
Low Forecast	$15.00

According to the 8 analysts' twelve-month price targets for Healthcare Realty Trust, the average price target is $17.00. The highest price target for HR is $18.00, while the lowest price target for HR is $15.00. The average price target represents a forecasted downside of -5.69% from the current price of $18.03.

Type	Current Forecast 9/19/23 to 9/18/24	1 Month Ago 8/20/23 to 8/19/24	3 Months Ago 6/21/23 to 6/20/24	1 Year Ago 9/19/22 to 9/19/23
Consensus Rating	Hold	Hold	Hold	Hold
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	2 Buy rating(s)	2 Buy rating(s)	2 Buy rating(s)	0 Buy rating(s)
Hold	5 Hold rating(s)	6 Hold rating(s)	8 Hold rating(s)	5 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$17.00	$17.00	$17.40	$20.75
Forecasted Upside	-5.69% Downside	6.34% Upside	10.94% Upside	11.10% Upside

Central Bank Abandons USD (Ad)

Startling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – the United States Dollar… And placing a ‘quiet bet’ on a new type of currency… Gold.

Click here now to get your free 'Protect Your Wealth' Guide.

HR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

HR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Healthcare Realty Trust Stock vs. The Competition

Type	Healthcare Realty Trust	Finance Companies	S&P 500
Consensus Rating Score	2.13	2.47	2.50
Consensus Rating	Hold	Hold	Moderate Buy
Predicted Upside	-6.39% Downside	13.97% Upside	7.61% Upside
News Sentiment Rating	Positive News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
8/7/2024	Scotiabank 5 of 5 stars		Boost Target	Sector Perform ➝ Sector Perform	$17.00 ➝ $18.00	+0.95%
8/5/2024	Wedbush 3 of 5 stars	R. Anderson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Neutral ➝ Neutral	$15.00 ➝ $18.00	+2.86%
7/30/2024	Wells Fargo & Company 3 of 5 stars	J. Feldman Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Equal Weight ➝ Underweight	$17.00 ➝ $16.00	-10.66%
3/6/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$19.00 ➝ $17.00	+23.37%
2/20/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$19.00 ➝ $15.00	+4.46%
1/30/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Hold	$18.00	+8.86%
Central Bank Abandons USD (Ad) Startling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – the United States Dollar… And placing a ‘quiet bet’ on a new type of currency… Gold. Click here now to get your free 'Protect Your Wealth' Guide.
10/24/2023	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Buy	$17.00	+18.55%
10/6/2023	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Market Perform ➝ Market Perform	$20.00 ➝ $17.00	+13.18%
8/22/2023	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$19.00 ➝ $17.00	+2.38%
8/11/2023	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Equal Weight ➝ Equal Weight	$25.00 ➝ $24.00	+32.89%
3/6/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Neutral	$23.00 ➝ $20.00	+1.21%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 10:55 PM ET.

HR Forecast - Frequently Asked Questions

What is Healthcare Realty Trust's forecast for 2024?: According to the research reports of 8 Wall Street equities research analysts, the average twelve-month stock price forecast for Healthcare Realty Trust is $17.00, with a high forecast of $18.00 and a low forecast of $15.00.
Should I buy or sell Healthcare Realty Trust stock right now?: 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Healthcare Realty Trust in the last twelve months. There is currently 1 sell rating, 5 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" HR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HR, but not buy additional shares or sell existing shares.
Does Healthcare Realty Trust's stock price have much upside?: According to analysts, Healthcare Realty Trust's stock has a predicted upside of 6.86% based on their 12-month stock forecasts.
Has Healthcare Realty Trust been downgraded by Wall Street analysts recently?: Over the previous 90 days, Healthcare Realty Trust's stock had 1 downgrade by analysts.
What analysts cover Healthcare Realty Trust?: Healthcare Realty Trust has been rated by research analysts at Scotiabank, Wedbush, and Wells Fargo & Company in the past 90 days.
Do Wall Street analysts like Healthcare Realty Trust more than its competitors?: Analysts like Healthcare Realty Trust less than other "finance" companies. The consensus rating score for Healthcare Realty Trust is 2.13 while the average consensus rating score for "finance" companies is 2.47. Learn more on how HR compares to other companies.